Atena Abed | Cancer | Innovative Research Award

Published on by Research Chemistry Awards

Innovative Research Award

Atena Abed
Affiliation Shahrekord University of Medical Science
Country Iran
Scopus ID 57218291844
Documents 8
Citations 238
h-index 4
Subject Area Cancer research
Award Innovative Research Award
Event International Research Chemistry Awards
ORCID 0000-0001-6408-5953

Atena Abed is a researcher affiliated with Shahrekord University of Medical Science in Iran whose identified subject area is cancer research. Her academic profile is associated with the Innovative Research Award presented under the International Research Chemistry Awards. The supplied bibliometric information records eight documents, citations, and an h-index. These indicators provide a quantitative overview of the research output and citation activity reported for the profile. [1]

Abstract

Atena Abed is a researcher affiliated with Shahrekord University of Medical Science, Iran, specializing in cancer research. Her profile is associated with the Innovative Research Award of the International Research Chemistry Awards. Her research profile and scholarly impact can be further evaluated through verified publications and bibliometric records.[1]

Keywords

Atena Abed; cancer research; oncology research; biomedical science; scientific innovation; research publications; citation analysis; h-index; scholarly impact; Innovative Research Award; International Research Chemistry Awards; Iran.[2]

Introduction

Cancer research is an interdisciplinary field that brings together molecular biology, biochemistry, genetics, pharmacology, pathology, clinical medicine, and data-driven approaches to improve the understanding and management of cancer. Research in this area can contribute to identifying disease-associated mechanisms, evaluating candidate therapeutic compounds, improving diagnostic approaches, and exploring strategies for prevention and patient care.[1]

Research Profile

Atena Abed is listed as affiliated with Shahrekord University of Medical Science, Iran. The supplied Scopus Author ID and the ORCID identifier . These identifiers provide routes to researcher records and can assist with distinguishing scholarly profiles when names or affiliations overlap. The completeness and current status of individual profile records should be confirmed directly through the relevant services.[2]

Research Contributions

Atena Abed, cancer research is the subject area specified in the supplied award profile. A detailed account of individual contributions would require examination of verified publications and their abstracts, methods, results, and conclusions. Without those records, it would be inappropriate to attribute particular discoveries, clinical applications, therapeutic advances, or laboratory techniques to the researcher.[3]

Publications

Publications are a principal means through which researchers communicate research questions, methods, results, and interpretations to the scientific community. Assessing an individual publication record requires consideration of the relevance and quality of the work, the research design, the contribution of each author, and the extent to which the findings have been validated or developed by subsequent studies.[4]

Research Impact

The supplied bibliometric indicators for Atena Abed comprise eight documents, citations, and an h-index. These measures describe different aspects of scholarly activity and should be interpreted together with the subject area, publication history, career stage, and nature of the research. Citation counts alone do not establish scientific quality, clinical relevance, methodological reliability, or societal benefit. [2]

Award Suitability

Innovation in research may involve the development of new methods, the generation of original scientific insights, the application of established techniques to new problems, or contributions that enable further investigation. A fair assessment should consider documented achievements and the quality of the evidence supporting the nomination.[3]

Conclusion

Atena Abed is presented in this academic profile as a researcher affiliated with Shahrekord University of Medical Science in Iran, with cancer research identified as the subject area and the Innovative Research Award listed under the International Research Chemistry Awards. The supplied record reports eight documents, citations.[4]

References

    1. Elsevier. (n.d.). Scopus author details: Atena Abed, Author ID 57218291844. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57218291844
    2. ORCID. (n.d.). ORCID record: 0000-0001-6408-5953.
      https://orcid.org/0000-0001-6408-5953
    3. International Research Chemistry Awards. (n.d.).
      https://researchchemistry.org/
    4. Dalilgo, H., Soleimani, Z., Esalatmanesh, K., Gilasi, H., Amini Mahabadi, J., & Abed, A. (2026). Investigation of the correlation between serum levels of interleukin-6 and clinical and paraclinical findings in COVID-19 patients. Current Therapeutic Research, Clinical and Experimental.
      https://doi.org/10.1016/j.curtheres.2026.100847

Prof. Wei Chong | Oncology | Best Researcher Award

Published on by Research Chemistry Awards

Prof. Wei Chong | Oncology | Best Researcher Award

Professor at Shandong Provincial Hospital China

Professional Profiles

Scopus

Orcid

🎓 Educational Background

Dr. Chong Wei has pursued a distinguished academic journey in the field of oncology and gastrointestinal research. She earned her Bachelor’s degree in Biotechnology from Shandong Second Medical University (2011-2015). She then obtained a Doctoral degree in Oncology from Tianjin Medical University Cancer Hospital (2015-2020), where she focused on cancer research and treatment strategies. Further advancing her expertise, she completed her Postdoctoral research in Surgery at Shandong Provincial Hospital (2021-2023), specializing in multi-omics molecular typing and precision treatment of digestive tract tumors.

🏥 Professional Experience

Dr. Chong Wei has made significant contributions to medical research and education. She began her career as a Research Assistant in the Department of Gastrointestinal Surgery at Shandong First Medical University Affiliated Provincial Hospital (2020-2022). She later became an Associate Professor at the Medical Science and Technology Innovation Center of Shandong First Medical University (2020-2025). Currently, she serves as a Postdoctoral Supervisor (since 2021) and Master’s Advisor (since 2022) in the Department of Gastrointestinal Surgery. Additionally, she holds the position of Deputy Director at the Laboratory of Basic and Clinical Oncology of Digestive Tract (since 2022).

🏆 Awards in Scientific and Technological Achievements

Dr. Chong Wei’s groundbreaking research has earned her multiple prestigious awards:

Shandong Province Science and Technology Progress Award (Second Prize, 2021) – For establishing a diagnostic and treatment system for colorectal cancer based on molecular markers and tumor microenvironment characteristics.

Third Prize of Youth Science and Technology Award (2023) – Recognized by the Shandong Medical Association for her work on tumor markers and precision diagnosis of digestive tract tumors.

First Prize of Science and Technology Award (2023) – Awarded by the Shandong Medical Engineering Society for her development of an automatic monitoring system for digestive tract tumor markers.

🏅 Honors & Recognitions

Dr. Chong Wei has received several prestigious accolades for her contributions to cancer research:

Excellence Award (2022) – Presented at the 17th National Gastric Cancer Academic Conference as part of the Gastric Cancer Future Scientist Award.

Third Prize (2024) – Received at the 18th National Gastric Cancer Academic Conference for her continued research on gastric cancer advancements.

Outstanding Poster Award (2022) – Honored by the Medical Science and Technology Innovation Center for presenting innovative research findings.

🔬 Research Focus & Impact

Dr. Chong Wei’s research centers on multi-omics molecular typing and precision medicine for digestive tract tumors. Her work aims to revolutionize cancer diagnosis and treatment through advanced molecular analysis and targeted therapeutic approaches. She has played a key role in developing tumor biomarker screening techniques that enhance the early detection and personalized treatment of gastrointestinal cancers.

👩‍🏫 Contributions to Medical Science & Education

Beyond her research, Dr. Chong Wei is committed to mentoring young scientists and medical professionals. As a Postdoctoral Supervisor and Master’s Advisor, she guides researchers in oncology and gastrointestinal studies, fostering innovation in clinical and laboratory research.

Noted Publications📝

Article: Mechanisms and therapeutic potential of the hedgehog signaling pathway in cancer
  • Authors: Ge Cong, Xingyu Zhu, Xin Ru Chen, Hao Chen, Wei Chong
    Journal: Cell Death Discovery
    Year: 2025
Article: Molecular characterization and clinical relevance of metabolic signature subtypes in gastric cancer
  • Authors: Chen H, Jing C, Shang L, Zhu X, Zhang R, Liu Y, Wang M, Xu K, Ma T, Jing H et al.
    Journal: Cell Reports
    Year: 2024
Article: Clinical features and molecular landscape of cuproptosis signature‐related molecular subtype in gastric cancer
  • Authors: Wei Chong, Huicheng Ren, Hao Chen, Kang Xu, Xingyu Zhu, Yuan Liu, Yaodong Sang, Han Li, Jin Liu, Chunshui Ye et al.
    Journal: iMeta
    Year: 2024
Article: Research progress of exosomes in the angiogenesis of digestive system tumour
  • Authors: Yuan Liu, Hao Wu, Yaodong Sang, Wei Chong, Liang Shang, Leping Li
    Journal: Discover Oncology
    Year: 2024
Article: Phospholysine phosphohistidine inorganic pyrophosphate phosphatase suppresses insulin-like growth factor 1 receptor expression to inhibit cell adhesion and proliferation in gastric cancer
  • Authors: Zhang Z, Wang X, Liu Y, Wu H, Zhu X, Ye C, Ren H, Chong W, Shang L, Li L
    Journal: MedComm
    Year: 2024

 

Dr. Swapan Ghosh | Cancer Drug Development | Medicinal Chemistry Breakthrough Award

Published on by Research Chemistry Awards

Dr. Swapan Ghosh | Cancer Drug Development | Medicinal Chemistry Breakthrough Award

Doctorate at Cancer Research Unit, Ramakrishna Mission Vivekananda Centenary College (Autonomous), India

Dr. Swapan Kumar Ghosh, an eminent scientist and professor, is widely recognized for his outstanding contributions to research in mycology, cancer biology, and environmental sustainability. A recipient of the prestigious Excellence in Research Award by UNICEF in 2021, he has dedicated over three decades to teaching and research. His work spans multiple fields, including anticancer compounds from mushrooms, biological control of plant pathogens, mosquito biocontrol using Trichoderma, microbial plastic degradation, and genotoxicity of food preservatives.

Professional Profiles

Google Scholar

🎓Academic Qualifications 

Dr. Ghosh has a strong academic background with degrees in botany and pathology:

               B.Sc. (Hons) in Botany with Human Physiology and Zoology.

               M.Sc. in Botany, specializing in Mycology and Pathology.

               Ph.D. in Plant Pathology from BCKV, Nadia, West Bengal.

🎓🔬Teaching & Research Experience 

With an extensive academic career, Dr. Ghosh has over 26 years of teaching experience in B.Sc. (Hons) in Botany and 13 years of teaching at the M.Sc. level. His 35 years of research experience have contributed significantly to multiple scientific fields, establishing him as a leader in biotechnology and microbiology research.

🔍Research Focus & Contributions 

Dr. Ghosh’s research spans various interdisciplinary areas, with significant contributions in:

               Anti-Cancer and Immune-Enhancing Agents – Investigating mushroom-derived compounds using human cancer cell lines and mice models.

               Biological Control of Plant Pathogens and Pests – Exploring fungi-based solutions for plant disease management.

               Biocontrol of Mosquitoes – Utilizing Trichoderma for eco-friendly mosquito control.

               Microbial Plastic Degradation – Studying the role of microbes in breaking down plastic waste.

               Genotoxicity of Food Preservatives – Assessing the impact of food preservatives on Drosophila models to ensure food safety.

🌍International Research Exposure 

Dr. Ghosh has engaged in collaborative research and international academic visits, enhancing his expertise. He visited:

               Harvard University, Boston, USA (2012).

               Chiang-Mai University, Thailand (2011).

He also worked with Prof. Ananda M Chakrabarty, the Father of Genetic Engineering, renowned for developing the Super Bug (Pseudomonas putida) at Illinois University, Chicago, USA.

📜Membership in Professional Organizations 

Dr. Ghosh is a Life Member of various prestigious academic and professional organizations, including:

               Association of Microbiologists of India (AMI) – ID: 4472-2016.

               Agro Environmental Development Society (AEDS), UP.

               Eurasian Academy of Environmental Science (EAES), Karnataka.

               SURYA, Jhansi, UP.

               SEBA, Kolkata.

Government & Scientific Advisory Roles 🏛️

Dr. Ghosh actively contributes to scientific policy-making and project evaluations:

               Member of the AYUSH and Medicinal Plant Board for R&D Project Evaluation, DSTBT, Government of West Bengal.

               Former Member (for 5 years) of the Agriculture Board for R&D Project Evaluation, DSTBT, Government of West Bengal.

NOTED PUBLICATIONS📄

Article: Study of microbes having potentiality for biodegradation of plastics
  • Authors: Swapan Kumar Ghosh, Sujoy Pal, Sumanta Ray
    Journal: Environmental Science and Pollution Research
    Year: 2013
Article: Zinc stress induces physiological, ultra-structural and biochemical changes in mandarin orange (Citrus reticulata Blanco) seedlings
  • Authors: Pratap Subba, Mainaak Mukhopadhyay, Suresh Kumar Mahato, Karma Diki Bhutia, Tapan Kumar Mondal, Swapan Kumar Ghosh
    Journal: Physiology and Molecular Biology of Plants
    Year: 2014
Article: Universal scaling laws of diffusion in a binary fluid mixture
  • Authors: Alok Samanta, Sk Musharaf Ali, Swapan K Ghosh
    Journal: Physical Review Letters
    Year: 2001
Article: Jute cellulose nano-fibrils/hydroxypropylmethylcellulose nanocomposite: A novel material with potential for application in packaging and transdermal drug delivery system
  • Authors: Jonathan Tersur Orasugh, Nayan Ranjan Saha, Dipak Rana, Gunjan Sarkar, Md Masud Rahaman Mollick, Atiskumar Chattoapadhyay, Bhairab Chandra Mitra, Dibyendu Mondal, Swapan Kumar Ghosh, Dipankar Chattopadhyay
    Journal: Industrial Crops and Products
    Year: 2018
Article: Construction of unpaved rural road using jute–synthetic blended woven geotextile–A case study
  • Authors: G Basu, AN Roy, SK Bhattacharyya, SK Ghosh
    Journal: Geotextiles and Geomembranes
    Year: 2009

 

Mr. Mahmoud Alfishawy | Radiation oncology | Best Researcher Award

Published on by Research Chemistry Awards

Mr. Mahmoud Alfishawy | Radiation oncology | Best Researcher Award

Mr. Mahmoud Alfishawy | Sultan Qaboos Comprehensive Cancer Care and Research Center, Oman

Professional Profiles

Google Scholar

Scopus

🎓Educational Background

Mahmoud Mohamed Alfishawy is currently a PhD candidate in the Biophysics Department at Al-Azhar University, Cairo, Egypt, since March 2021. He completed his Master of Biophysics at Ain Shams University, Cairo, Egypt, in September 2019, and holds a Diploma of Radiation Physics from the same university, awarded in September 2007. He earned his Bachelor of Science in Biophysics from Al-Azhar University, Cairo, Egypt, in May 2005.

💼Employment History 

Mahmoud has extensive experience in medical physics, particularly in radiation oncology. He currently serves as a Senior Medical Physicist at the Sultan Qaboos Comprehensive Cancer Center, a JCI-accredited hospital, where he has been employed since April 2021. Prior to this role, he worked at the International Medical Center (also JCI-accredited) from April 2008 to April 2021 as a Senior Medical Physicist. Mahmoud has also worked in various other prestigious hospitals, including Wadi El-Neel Hospital and As-Salam International Hospital, holding senior roles from January 2010 to April 2021. He began his career at Al-Hussein Hospital as a Medical Physicist from January 2006 to March 2008.

🔬Clinical Experience 

Mahmoud’s clinical expertise spans a wide range of radiation therapy machines, including CyberKnife, TrueBeam, Versa HD, Clinac, Cobalt 60, and others. He is experienced with advanced dosimetry systems, such as PTW and Sunnuclear, and patient-specific QA systems like Octavius 4D, Sunnuclear SRS Mapcheck, and Portal Dosimetry. His proficiency in radiation therapy techniques includes 3DCRT, IMRT, VMAT, IGRT, SRS, and SBRT, and he is adept at using treatment planning systems like Accuray Precision and Eclipse.

🏆Awards 

Mahmoud has received numerous accolades for his contributions to radiation therapy and dosimetry. Notably, he was a co-author of the MESTRO 2023 First Award for his abstract on In-Vivo Dosimetry using Diodes and Mosfets in Radiation Therapy. He also won the Proknow PSCO Plan Study 2024 First Award for a Head and Neck Case. Furthermore, he received two awards in the Arabian Radiotherapy Plan Competition 2019: First Award for 3DCRT and HYBRID (Craniospinal case) and Second Award for VMAT (Craniospinal case).

Publications Top Noted📝

Impact of flattening filter-free beams on remaining volume at risk in lung cancer treatment

Authors: Alfishawy, M.M., Kany, A.I., Elshahat, K.M.

Journal: Radiation and Environmental Biophysics

Year: 2024

Stereotactic radiotherapy: An educational narrative review

Authors: Khan, A.M.H., Hashmi, S.F.A., Li, B., Rassou, S.C., Mula-Hussain, L.

Journal: Precision Radiation Oncology

Year: 2024